Back to trial details

Intake questionnaire

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Applying to University of Illinois Cancer Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Extensive Stage Lung Small Cell Carcinoma?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chicago for study visits?